Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Nov 18, 2020
Date Accepted: Oct 24, 2021

The final, peer-reviewed published version of this preprint can be found here:

Assessing the Quality of Online Health Information About Breast Cancer from Chinese Language Websites: Quality Assessment Survey

Sun W, Luo A, Bian Z, Zhao B, Liu P, Wang K, Liu Y, Wang F

Assessing the Quality of Online Health Information About Breast Cancer from Chinese Language Websites: Quality Assessment Survey

JMIR Cancer 2021;7(4):e25783

DOI: 10.2196/25783

PMID: 34792471

PMCID: 8663447

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Assessing the quality of online health information about breast cancer from Chinese-language websites

  • Weiwei Sun; 
  • Aijing Luo; 
  • Zhiwei Bian; 
  • Bin Zhao; 
  • Peng Liu; 
  • Kai Wang; 
  • Yuwen Liu; 
  • Fuzhi Wang

ABSTRACT

Background:

In China, the Internet has become one of the most important ways to obtain information about breast cancer. However, quantitative evaluations of the quality of Chinese health websites and the breast cancer treatment information they publish are lacking.

Objective:

This study aimed to evaluate the quality of Chinese breast cancer websites and the value, suitability and accuracy of the breast cancer treatment information they publish.

Methods:

As the research objects, Chinese breast cancer health websites were searched and manually screened according to their Alexa and BaiduTM search engine rankings. For each site included in the survey, conducted April 8, 2019, three recently published articles that met the inclusion criteria were selected as samples to evaluate the quality of online breast cancer treatment information. Three raters assessed all materials using the LIDA, DISCERN, and SAM instruments and the Michigan Checklist. Data analysis was completed with SPSS 20.0 and Excel 2010.

Results:

This survey included 20 Chinese breast cancer websites and 60 articles on breast cancer treatment. The average LIDA score for the sites was 54.85 (SD 3.498). For the online breast cancer treatment articles, regarding value, the scores were generally low. Regarding suitability, 32 (53.33%) articles were evaluated as presenting unsuitable material. Regarding accuracy, the problems were that the articles were not original (44 articles, 73%) and lacked references (46 articles, 77%).

Conclusions:

The quality of Chinese breast cancer websites is generally good. However, the colour collocation, text setting and language design should be improved. The quality of Chinese online breast cancer treatment information is poor; the information has little value to users, and pictorial information is scarcely used. The online breast cancer treatment information is accurate but lacks originality and references.


 Citation

Please cite as:

Sun W, Luo A, Bian Z, Zhao B, Liu P, Wang K, Liu Y, Wang F

Assessing the Quality of Online Health Information About Breast Cancer from Chinese Language Websites: Quality Assessment Survey

JMIR Cancer 2021;7(4):e25783

DOI: 10.2196/25783

PMID: 34792471

PMCID: 8663447

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.